These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23224719)

  • 21. A longitudinal study of changes in endometrial microvascular density in Norplant implant users.
    Hickey M; Simbar M; Young L; Markham R; Russell P; Fraser IS
    Contraception; 1999 Feb; 59(2):123-9. PubMed ID: 10361627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen.
    Weisberg E; Merki-Feld GS; McGeechan K; Fraser IS
    Contraception; 2015 Feb; 91(2):121-6. PubMed ID: 25459098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokeratin 8, 18 and 19 in endometrial epithelium of Norplant and norethisterone enanthate injectable progestogen contraceptive users.
    Wonodirekso S; Hadisaputra W; Affandi B; Siregar B; Rogers PA
    Hum Reprod; 1996 Oct; 11 Suppl 2():144-9. PubMed ID: 8982756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokeratins 8, 18 and 19 in endometrial epithelial cells during the normal menstrual cycle and in women receiving Norplant.
    Wonodirekso S; Au CL; Hadisaputra W; Affandi B; Rogers PA
    Contraception; 1993 Nov; 48(5):481-93. PubMed ID: 7506133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transvaginal Doppler sonography for evaluation of irregular uterine bleeding with DMPA.
    Hussein M
    Arch Gynecol Obstet; 2011 Jun; 283(6):1325-8. PubMed ID: 20582427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in endometrial stromal cell tissue factor protein and messenger ribonucleic acid expression in patients experiencing abnormal uterine bleeding while using Norplant-2 contraception.
    Runic R; Schatz F; Krey L; Demopoulos R; Thung S; Wan L; Lockwood CJ
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1983-8. PubMed ID: 9177417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of switching with oral contraceptives.
    Wassef SA; Sami G; Hamid EA
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):77-93. PubMed ID: 12254511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Steroids and endometrial breakthrough bleeding: future directions for research.
    Smith SK
    Hum Reprod; 2000 Aug; 15 Suppl 3():197-202. PubMed ID: 11041236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endometrial biopsy collection from women receiving Norplant.
    Hadisaputra W; Affandi B; Witjaksono J; Rogers PA
    Hum Reprod; 1996 Oct; 11 Suppl 2():31-4. PubMed ID: 8982743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaginal bleeding disturbances and implantable contraceptives.
    Hickey M; d'Arcangues C
    Contraception; 2002 Jan; 65(1):75-84. PubMed ID: 11861057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endometrial lymphomyeloid cells in abnormal uterine bleeding due to levonorgestrel (Norplant).
    Clark DA; Wang S; Rogers P; Vince G; Affandi B
    Hum Reprod; 1996 Jul; 11(7):1438-44. PubMed ID: 8671483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
    Luukkainen T; Toivonen J
    Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful treatment of depot medroxyprogesterone acetate-related vaginal bleeding improves continuation rates in adolescents.
    Rager KM; Fowler A; Omar HA
    ScientificWorldJournal; 2006 Mar; 6():353-5. PubMed ID: 16547584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endometrial bleeding during hormone therapy: the effect of progestogens.
    Archer DF
    Maturitas; 2007 May; 57(1):71-6. PubMed ID: 17412535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
    Modesto W; Bahamondes MV; Bahamondes L
    Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
    Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF
    Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contraceptive and endometrial effects of medroxyprogesterone acetate.
    Lee RA
    Am J Obstet Gynecol; 1969 May; 104(1):130-3. PubMed ID: 5777697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unscheduled vaginal bleeding with progestin-only contraceptive use.
    Zigler RE; McNicholas C
    Am J Obstet Gynecol; 2017 May; 216(5):443-450. PubMed ID: 27988268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A three-year comparative study of continuation rates, bleeding patterns and satisfaction in Australian women using a subdermal contraceptive implant or progestogen releasing-intrauterine system.
    Weisberg E; Bateson D; McGeechan K; Mohapatra L
    Eur J Contracept Reprod Health Care; 2014 Feb; 19(1):5-14. PubMed ID: 24229367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of the endometrial changes in Norplant users.
    Wan LS
    Ann N Y Acad Sci; 1997 Sep; 828():108-10. PubMed ID: 9329828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.